Litcius/Paper detail

Interstitial glucose monitoring, type 1 diabetes and COVID-19 vaccine: the patient-reported outcomes and vaccine-associated changes in glucose and side effects (PRO-VACS)

Ilaria Dicembrini, Valentina Vitale, Claudia Cosentino, Barbara Cresci, Laura Pala, Maria Pieri, Dimitri Yannas, Matteo Vannucci, Elena Zago, Alessia Romani, Chiara Delli Poggi, Sara Liana Mariani, Daniele Scoccimarro, Carlotta Cocchetti, Matteo Monami, Edoardo Mannucci

2022Acta Diabetologica16 citationsDOIOpen Access PDF

Topics & Concepts

MedicineCoronavirus disease 2019 (COVID-19)Continuous glucose monitoringDiabetes mellitusSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Type 1 diabetesType 2 diabetes2019-20 coronavirus outbreakVirologyIntensive care medicineInternal medicineEndocrinologyDiseaseOutbreakInfectious disease (medical specialty)SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesDiabetes and associated disorders
Interstitial glucose monitoring, type 1 diabetes and COVID-19 vaccine: the patient-reported outcomes and vaccine-associated changes in glucose and side effects (PRO-VACS) | Litcius